Pharmafile Logo

New appointments in our UK and New York offices

Research Partnership is delighted to announce various appointments across our offices. Ella Buckland joins as Research Executive, Ines Belchior joins as Research Analyst, and Emma Warburton joins as Business Development Executive, all three to be based in the UK headquarters. Aaron Platt joined as Senior Research Executive and Dominika Klubek joined as Research Manager, both within the MedTech team and Austin Andrews joined as Research Analyst – they will reside in the New York office…

Ella, who studied Chemistry at the University of Bath, has experience working in market research across a range of immunology diseases, specifically in dermatology. Ines has previous experience conducting social and market research in a communications and strategy consultancy. She studied International Politics at City, University of London.
Emma has previous experience working as a pricing and market research analyst. She studied global health and received a master’s degree in international health policy from London School of Economics.

Austin Andrews attended Bucknell University in Pennsylvania where he got his B.A. in Biology and Psychology.

Aaron Platt received his undergraduate degree in sociology from New York University and his master’s degree in sociology from the University of California, Berkeley, where he is also currently working on his doctoral dissertation. He has worked in social science research, both quantitative and qualitative, for 11 years, working on projects for pharmaceutical and healthcare-related non-profit organisations.

Dominika has previous experience in leading primarily quant studies across a broad range of industries from consumer health to CPG and retail. She worked at Lieberman Research for 5 years with a strong focus in pharmaceuticals. Dominika has her master’s degree in industrial and organizational psychology from Hofstra University in Long Island.

Jon Ford has joined the London headquarters as in-house Recruitment Consultant, a newly created role to support demand for additional talent. He previously spent 4 years at Trace Recruitment where he focused on head hunting and recruitment in the Market Research and Brand Strategy sectors.

Speaking about the new appointments, Founding Director Mary Assimakopoulos said, “We are delighted to welcome our new hires and look forward to making further recruitment announcements in the near future .”

Find out more about a career with us »

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

The Next Billion Patients

Marc Yates, Director of Emerging Markets at pharma market research specialist Research Partnership, shares insights from his experience of working in BRIC and beyond.

Huge Untapped Growth Potential of ASEAN

Marc Yates, Director of Emerging Markets at pharma market research specialist Research Partnership, shares insights from his experience of working in BRIC and beyond.

The power of observation in gathering patient insights

Mary Assimakopoulos, Founding Director of global pharma market research specialist Research Partnership discusses how pharma can benefit from improved patient understanding.

Market Insights Can Deliver a Better Patient Experience

Mary Assimakopoulos, Founding Director of global pharma market research specialist Research Partnership discusses how pharma can benefit from improved patient understanding

Excellence in oncology: Developing an effective biomarker strategy

Oncology is arguably the most exciting area of medicine in which to be working today. Biomarkers and companion diagnostics offer incredibly valuable predictive power, which is of benefit to payers,...

Warehousing of HCV patients reaches new high

A new study conducted by Research Partnership reveals that 90% of physicians treating HCV patients in the US have reported they are now “warehousing” patients (holding off treatment) in expectation...

Brand leaders in RA will lose market share, predict rheumatologists

Rheumatologists believe that the current market for biologic treatments in Rheumatoid Arthritis (RA) will see key changes in the next three years.

Removing the Roadblocks to Effective Patient Treatment

How can pharma benefit from improved patient understanding? Welcome to a new column in which Mary Assimakopoulos, Founding Director of pharma market research specialist the Research Partnership reveals findings from...

Driving Earlier Diagnosis: A Case Study in Psoriatic Arthritis

Following a survey of 1000 Psoriatic Arthritis patients, Mary Assimakopoulos shares some of the root causes behind a late diagnosis of this debilitating illness, and the patients’ own feelings towards...

The Difficulties of Living with Depression Don’t End with the Illness Itself

This month Mary Assimakopoulos examines some of the insights gathered while surveying 2,000 patients suffering with this often misunderstood mental illness.